文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

tRNA修饰对癌症翻译的影响:确定新的治疗途径。

The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues.

作者信息

Añazco-Guenkova Ana M, Miguel-López Borja, Monteagudo-García Óscar, García-Vílchez Raquel, Blanco Sandra

机构信息

Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC) - University of Salamanca, 37007 Salamanca, Spain.

Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, 37007 Salamanca, Spain.

出版信息

NAR Cancer. 2024 Mar 12;6(1):zcae012. doi: 10.1093/narcan/zcae012. eCollection 2024 Mar.


DOI:10.1093/narcan/zcae012
PMID:38476632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10928989/
Abstract

Recent advancements have illuminated the critical role of RNA modifications in post-transcriptional regulation, shaping the landscape of gene expression. This review explores how tRNA modifications emerge as critical players, fine-tuning functionalities that not only maintain the fidelity of protein synthesis but also dictate gene expression and translation profiles. Highlighting their dysregulation as a common denominator in various cancers, we systematically investigate the intersection of both cytosolic and mitochondrial tRNA modifications with cancer biology. These modifications impact key processes such as cell proliferation, tumorigenesis, migration, metastasis, bioenergetics and the modulation of the tumor immune microenvironment. The recurrence of altered tRNA modification patterns across different cancer types underscores their significance in cancer development, proposing them as potential biomarkers and as actionable targets to disrupt tumorigenic processes, offering new avenues for precision medicine in the battle against cancer.

摘要

最近的进展揭示了RNA修饰在转录后调控中的关键作用,塑造了基因表达的格局。本综述探讨了tRNA修饰如何成为关键参与者,微调其功能,这些功能不仅维持蛋白质合成的保真度,还决定基因表达和翻译谱。突出它们的失调是各种癌症的共同特征,我们系统地研究了胞质和线粒体tRNA修饰与癌症生物学的交叉点。这些修饰影响细胞增殖、肿瘤发生、迁移、转移、生物能量学以及肿瘤免疫微环境调节等关键过程。不同癌症类型中tRNA修饰模式改变的反复出现凸显了它们在癌症发展中的重要性,提出它们作为潜在的生物标志物以及破坏肿瘤发生过程的可操作靶点,为抗癌精准医学提供了新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/990b/10928989/ff452bf1ff60/zcae012fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/990b/10928989/14d52f12288e/zcae012figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/990b/10928989/064b9e60affd/zcae012fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/990b/10928989/b7bac1533466/zcae012fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/990b/10928989/ff452bf1ff60/zcae012fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/990b/10928989/14d52f12288e/zcae012figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/990b/10928989/064b9e60affd/zcae012fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/990b/10928989/b7bac1533466/zcae012fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/990b/10928989/ff452bf1ff60/zcae012fig3.jpg

相似文献

[1]
The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues.

NAR Cancer. 2024-3-12

[2]
Exploring the role of ribosomal RNA modifications in cancer.

Curr Opin Genet Dev. 2024-6

[3]
Decoding the role of tRNA modifications in cancer progression.

Curr Opin Genet Dev. 2024-10

[4]
The functions and modifications of tRNA-derived small RNAs in cancer biology.

Cancer Metastasis Rev. 2025-3-12

[5]
tRNA modifications: insights into their role in human cancers.

Trends Cell Biol. 2023-12

[6]
Disruption of the RNA modifications that target the ribosome translation machinery in human cancer.

Mol Cancer. 2020-4-2

[7]
RNA modifications as a common denominator between tRNA and mRNA.

Curr Genet. 2021-8

[8]
Metabolism Meets Translation: Dietary and Metabolic Influences on tRNA Modifications and Codon Biased Translation.

Wiley Interdiscip Rev RNA. 2025

[9]
Role of RNA modifications in cancer metastasis.

Curr Opin Genet Dev. 2024-8

[10]
Pan-cancer analysis identifies tRNA modification enzyme CTU2 as a novel tumor biomarker and its role in immune microenvironment.

Front Immunol. 2025-5-1

引用本文的文献

[1]
tRNA pseudouridine synthase D (TruD) from modifies U13 in tRNA, tRNA, and tRNA and U35 in tRNA.

RNA. 2025-5-16

[2]
Toward the use of nanopore RNA sequencing technologies in the clinic: challenges and opportunities.

Nucleic Acids Res. 2025-2-27

[3]
N4-acetylcytidine and other RNA modifications in epitranscriptome: insight into DNA repair and cancer development.

Epigenomics. 2025-4

[4]
Queuosine tRNA Modification: Connecting the Microbiome to the Translatome.

Bioessays. 2025-2

[5]
Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer.

Nucleic Acids Res. 2024-12-11

[6]
Closing in on human methylation-the versatile family of seven-β-strand (METTL) methyltransferases.

Nucleic Acids Res. 2024-10-28

[7]
Variation of tRNA modifications with and without intron dependency.

Front Genet. 2024-9-4

[8]
Editorial: Translational control in cancer.

NAR Cancer. 2024-7-23

本文引用的文献

[1]
A connection between the ribosome and two S. pombe tRNA modification mutants subject to rapid tRNA decay.

PLoS Genet. 2024-1

[2]
Chemical Proteomic Discovery of Isotype-Selective Covalent Inhibitors of the RNA Methyltransferase NSUN2.

Angew Chem Int Ed Engl. 2023-12-18

[3]
METTL3 inhibition enhances anti-tumour immunity.

Nat Rev Cancer. 2023-10

[4]
N7-methylguanosine methylation of tRNAs regulates survival to stress in cancer.

Oncogene. 2023-10

[5]
Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity.

Cancer Discov. 2023-10-5

[6]
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer.

Mol Cancer. 2023-7-29

[7]
NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer.

Cell Rep. 2023-7-25

[8]
PUS1 is a novel biomarker for evaluating malignancy of human renal cell carcinoma.

Aging (Albany NY). 2023-6-13

[9]
N 2-methylguanosine modifications on human tRNAs and snRNA U6 are important for cell proliferation, protein translation and pre-mRNA splicing.

Nucleic Acids Res. 2023-8-11

[10]
METTL1/WDR4-mediated tRNA mG modification and mRNA translation control promote oncogenesis and doxorubicin resistance.

Oncogene. 2023-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索